Mathew Page, DPM
Foot & Ankle Surgery · Jackson, MINPI 1710002886
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (59.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Pinnacle, Inc at 42.7% of the total. Reporting peaked in 2024 at $936 and has fallen 90.7% since, to $87 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in MI, where the typical reported total is $3,214.
Across 33 payments — averaging $37.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$532
- Arthrex$333
- Paragon 28, Inc.$93
- Stryker$62
- Orthofix Medical, Inc.$42
- Smith+Nephew$42
- plus $142 from 8 others
What the payments were for
- Travel & lodging$74760%
- Food & beverage$48439%
- Education$161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 5 | $532 |
| Arthrex | 6 | $333 |
| Paragon 28, Inc. | 5 | $93 |
| Stryker(2 entities) | 2 | $62 |
| Orthofix Medical, Inc. | 4 | $42 |
| Smith+Nephew | 3 | $42 |
| Amgen | 1 | $22 |
| Vertex | 1 | $20 |
| Mimedx Group, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Nevro Corp. | 1 | $18 |
| Merck | 1 | $16 |
| Arthrosurface Incorporated | 1 | $14 |
| Linvatec Corporation | 1 | $12 |
How this compares
$1,247 in reported general payments places this provider in the 30th percentile of 384 foot & ankle surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 35 | $878 |
| Terbinafine Hcl | 23 | $344 |
| Doxycycline Hyclate | 32 | $236 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $134 |
| Mupirocin | 15 | $111 |
| Celecoxib | 15 | $108 |
| Ciprofloxacin Hcl | 12 | $59 |
| Cephalexin | 11 | $44 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $39 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Jackson
- Blake BrannickJackson$13K
- John AndersonGrand Rapids$1.3M
- Brian LoderClinton Township$854K
- Karl DunnClinton Twp$434K
- Anthony LalamaMacomb$421K
- Christopher ZingasSaint Clair Shores$227K
- John MaskillGrand Rapids$202K
- Michael SwordsLansing$189K
- Gregory SheremetaTroy$87K
- Jason WesloskyClinton Township$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.